Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KOD Kodiak Sciences Inc.

交易中 05-20 12:10:42 EDT

3.22

-0.08

-2.50%

最高3.32	最低3.19	成交量16.59万
今开3.30	昨收3.30	日振幅4.13%
总市值1.69亿	流通市值1.03亿	总股本5,238万
成交额53.45万	换手率0.52%	流通股本3,210万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":3.2175,"timestamp":1716221411772,"preClose":3.3,"halted":0,"volume":165900,"delay":0,"floatShares":32098317,"shares":52383231,"eps":-4.436927,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0825,"latestTime":"05-20 12:10:42 EDT","open":3.3,"high":3.3212,"low":3.185,"amount":534453.5191800001,"amplitude":0.041273,"askPrice":3.22,"askSize":200,"bidPrice":3.21,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-4.436927,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1716235200000},"adr":0,"listingDate":1538625600000,"adjPreClose":3.3,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.3,"preClose":3.3,"latestTime":"09:05 EDT","volume":151,"amount":496.735036,"timestamp":1716210316862},"postHourTrading":{"tag":"盘后","latestPrice":3.2981,"preClose":3.3,"latestTime":"19:31 EDT","volume":2054,"amount":6781.585,"timestamp":1715988694485},"volumeRatio":1.261148},"requestUrl":"/m/hq/s/KOD/tweets","defaultTab":"tweets","newsList":[{"id":"2435429736","title":"美国研究综述-AN2 Therapeutics、艺康公司、RPM 国际公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2435429736","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435429736?lang=zh_cn&edition=full","pubTime":"2024-05-16 14:53","pubTimestamp":1715842434,"startTime":"0","endTime":"0","summary":"    路透5月16日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 AN2 Therapeutics、艺康和 RPM International。要闻              * AN2 Therapeutics Inc   ：Evercore ISI将目标价从7美元下调至2美元             * Biolife Solutions Inc   ：Maxim Group将目标价从25美元上调至30美元             * Ecolab Inc   ：Evercore ISI将目标价从195美元上调至250美元             * RPM International Inc   ：Evercore ISI 将目标价从 110 美元上调至 130 美元             * Third Harmonic Bio Inc   ：杰富瑞将目标价从8.1美元上调至15美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435660993","title":"科迪亚克科学公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435660993","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435660993?lang=zh_cn&edition=full","pubTime":"2024-05-16 05:03","pubTimestamp":1715807019,"startTime":"0","endTime":"0","summary":"   * 科迪亚克科学公司  公布，在截至3月底的季度调整后每股亏损82美分，高于去年同期的每股收益1.35美元。六位分析师对该季度的平均预期是每股亏损 1.07 美元。华尔街预期为每股亏损 1.25 美元至-88 美分。* Kodiak Sciences Inc 公布的本季度每股收益为亏损 82 美分。* 该公司当季亏损 4,304 万美元。* 科迪亚克科学公司本季度股价下跌了 27.0%，今年迄今为止上涨了 26.3%。华尔街对 Kodiak Sciences Inc 的 12 个月目标价中位数为 4.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435376516","title":"Kodiak Sciences Inc盘中异动 大幅上涨5.26%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435376516","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435376516?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:07","pubTimestamp":1715609236,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时07分，Kodiak Sciences Inc股票出现异动，股价急速上涨5.26%。截至发稿，该股报3.80美元/股，成交量1.9929万股，换手率0.04%，振幅4.71%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为1.29%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132207177a599bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132207177a599bfa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434900968","title":"Kodiak Sciences Inc   预计每股亏损 1.07 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434900968","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434900968?lang=zh_cn&edition=full","pubTime":"2024-05-11 06:45","pubTimestamp":1715381125,"startTime":"0","endTime":"0","summary":"   * 科迪亚克科学公司   预计在5月13日发布业绩报告时，季度营收将不会有任何变化(预计)，截至2024年3月31日。*    * LSEG的分析师平均预计科迪亚克科学公司每股亏损1.07美元。* 在过去三个月中，分析师的平均盈利预期上升了约 4.9%。* 华尔街对 Kodiak Sciences Inc 的 12 个月目标价中值为 4.00 美元，高于其上一次收盘价 3.61 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434534898","title":"Kodiak Sciences Inc盘中异动 下午盘快速下跌5.00%报3.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434534898","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434534898?lang=zh_cn&edition=full","pubTime":"2024-05-11 02:34","pubTimestamp":1715366067,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日02时34分，Kodiak Sciences Inc股票出现波动，股价急速下挫5.00%。截至发稿，该股报3.61美元/股，成交量18.9907万股，换手率0.36%，振幅7.63%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.11%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051102342787e872de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051102342787e872de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434677919","title":"Kodiak Sciences Inc盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434677919","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434677919?lang=zh_cn&edition=full","pubTime":"2024-05-09 00:59","pubTimestamp":1715187561,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日00时59分，Kodiak Sciences Inc股票出现异动，股价大幅下跌5.28%。截至发稿，该股报3.77美元/股，成交量14.3857万股，换手率0.27%，振幅4.40%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.12%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050900592187e867e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050900592187e867e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433407133","title":"Kodiak Sciences Inc盘中异动 大幅拉升5.31%报3.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433407133","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433407133?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:55","pubTimestamp":1715014517,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日00时55分，Kodiak Sciences Inc股票出现异动，股价急速上涨5.31%。截至发稿，该股报3.97美元/股，成交量23.385万股，换手率0.45%，振幅5.42%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.19%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507005517861eb3ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507005517861eb3ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432797046","title":"Kodiak Sciences Inc盘中异动 大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432797046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432797046?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:30","pubTimestamp":1714743053,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时30分，Kodiak Sciences Inc股票出现异动，股价快速拉升5.14%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为58.18%、21.00%、10.09%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Relay Therapeutics, Inc.、Karyopharm Therapeutics Inc.，振幅分别为15.86%、13.56%、6.48%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032130537a57fb03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032130537a57fb03&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432507418","title":"Kodiak Sciences Inc盘中异动 股价大涨5.30%报3.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432507418","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432507418?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:41","pubTimestamp":1714578115,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日23时41分，Kodiak Sciences Inc股票出现异动，股价大幅拉升5.30%。截至发稿，该股报3.38美元/股，成交量9.0558万股，换手率0.17%，振幅4.05%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.79%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012341557925a2d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012341557925a2d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431865042","title":"Kodiak Sciences Inc盘中异动 股价大涨6.10%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431865042","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431865042?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:37","pubTimestamp":1714397848,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时37分，Kodiak Sciences Inc股票出现异动，股价大幅上涨6.10%。截至发稿，该股报3.48美元/股，成交量8265股，换手率0.02%，振幅3.35%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.84%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213728861ea174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213728861ea174&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430366270","title":"Kodiak Sciences Inc盘中异动 早盘急速上涨5.81%报3.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430366270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430366270?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:31","pubTimestamp":1714138309,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时31分，Kodiak Sciences Inc股票出现异动，股价快速上涨5.81%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Tevogen Bio Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为518.11%、68.05%、20.43%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Biodexa Pharmaceuticals Plc、Allarity Therapeutics, Inc.，振幅分别为34.80%、22.08%、18.81%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426213150861e9899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426213150861e9899&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430287776","title":"Kodiak Sciences Inc盘中异动 早盘股价大跌5.03%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430287776","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430287776?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:41","pubTimestamp":1714056094,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时41分，Kodiak Sciences Inc股票出现异动，股价快速跳水5.03%。截至发稿，该股报3.21美元/股，成交量4.1407万股，换手率0.08%，振幅2.07%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为1.92%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522413487e83c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522413487e83c54&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428340527","title":"Kodiak Sciences Inc盘中异动 急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428340527","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428340527?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:23","pubTimestamp":1713367393,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时23分，Kodiak Sciences Inc股票出现异动，股价大幅下跌5.14%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vanda Pharmaceuticals Inc.、Galera Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为151.56%、38.69%、38.53%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Dare Bioscience, Inc.，振幅分别为80.94%、50.74%、41.02%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723231487e8168f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723231487e8168f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427045460","title":"Kodiak Sciences Inc盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427045460","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427045460?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:28","pubTimestamp":1713191335,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时28分，Kodiak Sciences Inc股票出现波动，股价快速下跌5.22%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，安皮奥制药、Soligenix, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1214.27%、992.07%、738.17%，振幅较大的相关个股有安皮奥制药、Cassava Sciences Inc C/Wts 15/11/2024、Soligenix, Inc.，振幅分别为273.33%、80.04%、79.05%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041522285687e80785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041522285687e80785&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426923733","title":"Kodiak Sciences Inc盘中异动 快速拉升5.10%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426923733","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426923733?lang=zh_cn&edition=full","pubTime":"2024-04-09 03:58","pubTimestamp":1712606329,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日03时58分，Kodiak Sciences Inc股票出现异动，股价急速拉升5.10%。截至发稿，该股报4.33美元/股，成交量68.5443万股，换手率1.31%，振幅6.67%。机构评级方面，在所有6家参与评级的机构中，17%的券商给予买入建议，50%的券商给予持有建议，33%的券商给予卖出建议。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.18%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090358497a516b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090358497a516b55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424390140","title":"Kodiak Sciences Inc盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424390140","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424390140?lang=zh_cn&edition=full","pubTime":"2024-04-04 22:02","pubTimestamp":1712239339,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日22时02分，Kodiak Sciences Inc股票出现异动，股价大幅拉升5.04%。截至发稿，该股报4.49美元/股，成交量7.4719万股，换手率0.14%，振幅4.17%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.37%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404220220791ecd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404220220791ecd7c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424043025","title":"Kodiak Sciences Inc盘中异动 早盘股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424043025","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424043025?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:32","pubTimestamp":1712064770,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时32分，Kodiak Sciences Inc股票出现异动，股价急速下挫5.62%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Aditxt, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Aditxt, Inc.、Imunon, Inc.、Vbi Vaccines, Inc.较为活跃，换手率分别为462.86%、10.45%、10.12%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Trevena, Inc.，振幅分别为48.62%、20.44%、11.75%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022132507a50b5ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022132507a50b5ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423566441","title":"Kodiak Sciences Inc2023财年实现净利润-2.60亿美元，同比增加22.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423566441","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2423566441?lang=zh_cn&edition=full","pubTime":"2024-03-30 06:14","pubTimestamp":1711750452,"startTime":"0","endTime":"0","summary":"12月31日，Kodiak Sciences Inc公布财报，公告显示公司2023财年净利润为-2.60亿美元，同比增加22.16%；其中营业收入为0.00美元，每股基本收益为-4.97美元。从资产负债表来看，Kodiak Sciences Inc总负债2.14亿美元，其中短期债务9.77百万美元，资产负债比为2.24，流动比率为0.07。机构评级：截至2023年12月31日，当前有2家机构对Kodiak Sciences Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为3.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024033006142087c6dff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024033006142087c6dff5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423112976","title":"科迪亚克科学公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2423112976","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2423112976?lang=zh_cn&edition=full","pubTime":"2024-03-29 05:03","pubTimestamp":1711659794,"startTime":"0","endTime":"0","summary":"   * 科迪亚克科学公司  公布了截至12月底的季度调整后每股亏损1.13美元，高于去年同期的每股亏损1.35美元。六位分析师对该季度的平均预期是每股亏损 77 美分。华尔街预期为每股-95美分至-54美分。* Kodiak Sciences Inc 报告的本季度每股收益为亏损 1.13 美元。* 该公司当季亏损5952万美元。* 本季度，Kodiak Sciences Inc 的股价上涨了 145.1%。华尔街对 Kodiak Sciences Inc 的 12 个月目标价中位数为 3.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422717913","title":"Kodiak Sciences Inc盘中异动 快速拉升5.21%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422717913","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422717913?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:24","pubTimestamp":1711549466,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时24分，Kodiak Sciences Inc股票出现波动，股价大幅拉升5.21%。截至发稿，该股报7.47美元/股，成交量13.4637万股，换手率0.26%，振幅5.07%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.54%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032722242687e7c506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032722242687e7c506&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com","stockEarnings":[{"period":"1week","weight":-0.0859},{"period":"1month","weight":-0.0833},{"period":"3month","weight":-0.39},{"period":"6month","weight":0.3253},{"period":"1year","weight":-0.382},{"period":"ytd","weight":0.0855}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kodiak Sciences Inc.于2009年6月22日以Oligasis LLC的名义成立为有限责任公司。2015年9月8日更名并在特拉华州注册成立公司。该公司是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法。Kodiak Sciences Inc.最先进的候选产品是KSI-301，一种用抗体生物聚合物共轭平台或ABC平台构建的生物疗法，旨在维持眼组织中有效和有效的药物水平。Kodiak Sciences Inc.认为，如果获得批准，KSI-301有可能成为湿性年龄相关性黄斑变性，湿性AMD和糖尿病性视网膜病变或DR的重要抗VEGF治疗。KSI-301及其ABC平台是在Kodiak开发的，他们拥有这些资产的全球权利，包括KSI-301的物质专利保护组成。Kodiak Sciences Inc.已经应用他们的ABC平台开发了除KSI-301之外的其他候选产品，包括KSI-501，他们的双特异性抗IL-6/VEGF生物共轭物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.011633},{"month":2,"riseRate":0.5,"avgChangeRate":-0.09488},{"month":3,"riseRate":0,"avgChangeRate":-0.119998},{"month":4,"riseRate":0.5,"avgChangeRate":-0.092981},{"month":5,"riseRate":0.833333,"avgChangeRate":0.132087},{"month":6,"riseRate":0.8,"avgChangeRate":0.07057},{"month":7,"riseRate":0.4,"avgChangeRate":-0.090922},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021231},{"month":9,"riseRate":0.6,"avgChangeRate":0.008735},{"month":10,"riseRate":0.6,"avgChangeRate":0.185407},{"month":11,"riseRate":0.666667,"avgChangeRate":0.224808},{"month":12,"riseRate":0.5,"avgChangeRate":0.237125}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况